Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
October 15, 2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, et al.
Clinical Pharmacokinetics
|
October 31, 2020
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression
Carlos Perez-Ruixo, Stefaan Rossenu, Peter Zannikos, et al.
Clinical Pharmacokinetics
|
October 16, 2016
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia
Mats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
British Journal of Clinical Pharmacology
|
January 17, 2012
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes
Xu Steven Xu, Kenneth Moore, Paul Burton, et al.
Journal of Pharmaceutical Sciences
|
September 27, 2014
Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers
Filippos Kesisoglou, Stefaan Rossenu, Colm Farrell, et al.
Journal of Clinical Pharmacology
|
August 29, 2009
Single- and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended release
Sandra Boom, Krishna Talluri, Luc Janssens, et al.
Clinical Pharmacology in Drug Development
|
May 4, 2016
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia
Stefaan Rossenu, Adriaan Cleton, David Hough, et al.
Blood
|
September 6, 2012
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
Filip Callewaert, Jan Roodt, Hans Ulrichts, et al.
Journal of Molecular Biology
|
May 16, 2006
Identification of the PXW sequence as a structural gatekeeper of the headpiece C-terminal subdomain fold
Wim Vermeulen, Marleen Van Troys, David Bourry, et al.
Journal of Clinical Pharmacology
|
March 29, 2014
A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
Adriaan Cleton, Stefaan Rossenu, Herta Crauwels, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Journal of Psychopharmacology (Oxford, England)
|
October 15, 2009
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Joris Berwaerts, Adriaan Cleton, Stefaan Rossenu, et al.
Clinical Pharmacokinetics
|
October 31, 2020
Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression
Carlos Perez-Ruixo, Stefaan Rossenu, Peter Zannikos, et al.
Clinical Pharmacokinetics
|
October 16, 2016
Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia
Mats O Magnusson, Mahesh N Samtani, Elodie L Plan, et al.
British Journal of Clinical Pharmacology
|
January 17, 2012
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes
Xu Steven Xu, Kenneth Moore, Paul Burton, et al.
Journal of Pharmaceutical Sciences
|
September 27, 2014
Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers
Filippos Kesisoglou, Stefaan Rossenu, Colm Farrell, et al.
Journal of Clinical Pharmacology
|
August 29, 2009
Single- and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended release
Sandra Boom, Krishna Talluri, Luc Janssens, et al.
Clinical Pharmacology in Drug Development
|
May 4, 2016
Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia
Stefaan Rossenu, Adriaan Cleton, David Hough, et al.
Blood
|
September 6, 2012
Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura
Filip Callewaert, Jan Roodt, Hans Ulrichts, et al.
Journal of Molecular Biology
|
May 16, 2006
Identification of the PXW sequence as a structural gatekeeper of the headpiece C-terminal subdomain fold
Wim Vermeulen, Marleen Van Troys, David Bourry, et al.
Journal of Clinical Pharmacology
|
March 29, 2014
A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
Adriaan Cleton, Stefaan Rossenu, Herta Crauwels, et al.
Page
of 3